Petros Perros

Summary

Affiliation: University of Newcastle
Country: UK

Publications

  1. ncbi request reprint Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience
    P Perros
    Freeman Hospital, Newcastle upon Tyne, United Kingdom
    J Endocrinol Invest 22:30-4. 1999
  2. ncbi request reprint rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review
    Markus Luster
    Department of Nuclear Medicine, University of Wurzburg, Josef Schneider Str 2, 97080 Wurzburg, Germany
    Endocr Relat Cancer 12:49-64. 2005
  3. pmc Orbital decompression for Graves' orbitopathy in England
    P Perros
    Department of Endocrinology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Eye (Lond) 26:434-7. 2012
  4. ncbi request reprint Radioiodine uptake in normal female breasts and liver of a patient with differentiated thyroid cancer imaged by whole body scanning
    P Perros
    Endocrine Unit, Freeman Hospital, Newcastle upon Tyne NE7 7N, United Kingdom
    Thyroid 13:511. 2003
  5. ncbi request reprint Orbital irradiation for thyroid-associated orbitopathy: conventional dose, low dose or no dose?
    Petros Perros
    Endocrine Unit, Freeman Hospital, Newcastle upon Tyne, UK
    Clin Endocrinol (Oxf) 56:689-91. 2002
  6. ncbi request reprint Medical treatment for thyroid-associated ophthalmopathy
    Petros Perros
    Department of Endocrinology, University of Newcastle upon Tyne, United Kingdom
    Thyroid 12:241-4. 2002
  7. pmc A 69-year-old female with tiredness and a persistent tan
    Petros Perros
    Freeman Hospital, Newcastle upon Tyne, United Kingdom
    PLoS Med 2:e229. 2005
  8. ncbi request reprint A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy
    Petros Perros
    Endocrine Unit, Freeman Hospital, Freeman Road, Newcastle upon Tyne NE7 7DN, United Kingdom
    J Clin Endocrinol Metab 90:5321-3. 2005
  9. ncbi request reprint Prevalence of pernicious anaemia in patients with Type 1 diabetes mellitus and autoimmune thyroid disease
    P Perros
    Department of Diabetes, Royal Infirmary, Edinburgh, Scotland, UK
    Diabet Med 17:749-51. 2000
  10. ncbi request reprint Evaluation of an on-call diabetes service in a large teaching hospital
    P Perros
    Department of Diabetes, Royal Infirmary, Edinburgh, Scotland, UK
    Diabet Med 17:386-9. 2000

Collaborators

Detail Information

Publications55

  1. ncbi request reprint Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience
    P Perros
    Freeman Hospital, Newcastle upon Tyne, United Kingdom
    J Endocrinol Invest 22:30-4. 1999
    ..Therapeutic use of rhTSH may be considered in an increasing number of other cases...
  2. ncbi request reprint rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review
    Markus Luster
    Department of Nuclear Medicine, University of Wurzburg, Josef Schneider Str 2, 97080 Wurzburg, Germany
    Endocr Relat Cancer 12:49-64. 2005
    ....
  3. pmc Orbital decompression for Graves' orbitopathy in England
    P Perros
    Department of Endocrinology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Eye (Lond) 26:434-7. 2012
    ..The purpose of this study was to obtain data on orbital decompression procedures performed in England, classed by hospital and locality, to evaluate regional variation in care...
  4. ncbi request reprint Radioiodine uptake in normal female breasts and liver of a patient with differentiated thyroid cancer imaged by whole body scanning
    P Perros
    Endocrine Unit, Freeman Hospital, Newcastle upon Tyne NE7 7N, United Kingdom
    Thyroid 13:511. 2003
  5. ncbi request reprint Orbital irradiation for thyroid-associated orbitopathy: conventional dose, low dose or no dose?
    Petros Perros
    Endocrine Unit, Freeman Hospital, Newcastle upon Tyne, UK
    Clin Endocrinol (Oxf) 56:689-91. 2002
  6. ncbi request reprint Medical treatment for thyroid-associated ophthalmopathy
    Petros Perros
    Department of Endocrinology, University of Newcastle upon Tyne, United Kingdom
    Thyroid 12:241-4. 2002
    ..Several drugs have been used. Systemic steroids seem to be beneficial in patients with active disease. The evidence for the remaining drugs reported to be potentially useful, is unconvincing...
  7. pmc A 69-year-old female with tiredness and a persistent tan
    Petros Perros
    Freeman Hospital, Newcastle upon Tyne, United Kingdom
    PLoS Med 2:e229. 2005
  8. ncbi request reprint A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy
    Petros Perros
    Endocrine Unit, Freeman Hospital, Freeman Road, Newcastle upon Tyne NE7 7DN, United Kingdom
    J Clin Endocrinol Metab 90:5321-3. 2005
    ..Radioiodine is an effective and safe treatment for hyperthyroidism but has been implicated as a risk factor for deterioration or new presentation of Graves' ophthalmopathy (GO). Prophylactic glucocorticoids appear to prevent this effect...
  9. ncbi request reprint Prevalence of pernicious anaemia in patients with Type 1 diabetes mellitus and autoimmune thyroid disease
    P Perros
    Department of Diabetes, Royal Infirmary, Edinburgh, Scotland, UK
    Diabet Med 17:749-51. 2000
    ..To determine the prevalence of pernicious anaemia in patients with Type 1 diabetes mellitus and autoimmune thyroid disease...
  10. ncbi request reprint Evaluation of an on-call diabetes service in a large teaching hospital
    P Perros
    Department of Diabetes, Royal Infirmary, Edinburgh, Scotland, UK
    Diabet Med 17:386-9. 2000
    ..To assess prospectively the activity and effectiveness of a diabetes specialist on-call service...
  11. pmc Thyrotoxicosis and pregnancy
    Petros Perros
    Endocrine Unit, Freeman Hospital, Newcastle upon Tyne, United Kingdom
    PLoS Med 2:e370. 2005
  12. ncbi request reprint A questionnaire survey on the management of Graves' orbitopathy in Europe
    P Perros
    Department of Endocrinology, Freeman Hospital, Newcastle upon Tyne, UK, and Department of Ophthalmology, Orbital Center, Academic Medical Center, Amsterdam, The Netherlands
    Eur J Endocrinol 155:207-11. 2006
    ..To determine management patterns among clinicians who treat patients with Graves' orbitopathy (GO) in Europe...
  13. ncbi request reprint Analysis of peripheral blood T-cell subsets in active thyroid-associated ophthalmopathy: absence of effect of octreotide-LAR on T-cell subsets in patients with thyroid-associated ophthalmopathy
    Bijay Vaidya
    Department of Endocrinology, Newcastle University, Newcastle upon Tyne, United Kingdom
    Thyroid 15:1073-8. 2005
    ..These results support a role of T cell in the pathogenesis of TAO, and show that octreotide-LAR has no effect on T-cell subsets during 32-weeks of treatment...
  14. ncbi request reprint Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia
    Stewart C Ferguson
    Department of Diabetes, The Royal Infirmary of Edinburgh, Edinburgh, U K
    Diabetes 52:149-56. 2003
    ..Chronic hyperglycemia (inferred by the presence of background diabetic retinopathy) may affect brain structure and function...
  15. doi request reprint Residual adrenal function in autoimmune Addison's disease: improvement after tetracosactide (ACTH1-24) treatment
    Earn H Gan
    Institute of Genetic Medicine E H G, K M, A L M, P P, R Q, S H S P, Newcastle University, Newcastle upon Tyne NE1 3BZ, United Kingdom the Endocrine Unit E H G, A L M, P P, S G B, R A J, R Q, S H S P, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, United Kingdom the Centre for Endocrinology, Diabetes, and Metabolism B A H, W A, University of Birmingham, Birmingham B15 2TT, United Kingdom and RSR Ltd S C, J F, FIRS Laboratories, Cardiff CF4 5DU, United Kingdom
    J Clin Endocrinol Metab 99:111-8. 2014
    ..In health, adrenocortical cells undergo continuous self-renewal from a population of subcapsular progenitor cells, under the influence of ACTH, suggesting a therapeutic possibility...
  16. doi request reprint The effect of B cell depletion therapy on anti-TSH receptor antibodies and clinical outcome in glucocorticoid-refractory Graves' orbitopathy
    Anna L Mitchell
    Institute of Genetic Medicine, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, UK
    Clin Endocrinol (Oxf) 79:437-42. 2013
    ..This case series documents the response of nine individuals with glucocorticoid-refractory Graves' orbitopathy (GO) to B cell depletion therapy with rituximab (RTX)...
  17. ncbi request reprint Early response to intravenous glucocorticoids for severe thyroid-associated ophthalmopathy predicts treatment outcome
    Richard H Hart
    Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
    J Ocul Pharmacol Ther 21:328-36. 2005
    ..The results for 18 consecutive patients with severe thyroid-associated ophthalmopathy (TAO) treated with high-dose, pulsed intravenous methylprednisolone (MP) are presented in this paper...
  18. ncbi request reprint Serum thyrotropin is a better predictor of future thyroid dysfunction than thyroid autoantibody status in biochemically euthyroid patients with diabetes: implications for screening
    Roderick E Warren
    Department of Diabetes, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
    Thyroid 14:853-7. 2004
    ..To ascertain the predictive values of thyroid autoantibodies and thyrotropin (TSH) levels for subsequent thyroid dysfunction in patients with diabetes...
  19. ncbi request reprint Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up
    David R Weightman
    Endocrine Unit, Freeman Hospital, Newcastle upon Tyne, United Kingdom
    Cancer 98:41-7. 2003
    ..Serum thyroglobulin measurement is an integral part of monitoring patients with thyroid carcinoma, but analytic problems pose serious difficulties in the utility of this test...
  20. ncbi request reprint Phaeochromocytomas presenting as acute crises after beta blockade therapy
    L Sibal
    Department of Endocrinology, Newcastle upon Tyne Acute Hospitals, Newcastle upon Tyne, UK
    Clin Endocrinol (Oxf) 65:186-90. 2006
    ..We analysed, retrospectively, the presentation, management and outcome of patients who were admitted to our institution with phaeochromocytoma crises over a 5-year period...
  21. ncbi request reprint Serum S-100beta protein is a potential biochemical marker for cerebral oedema complicating severe diabetic ketoacidosis
    E A McIntyre
    Medical Unit 3, Freeman Hospital, Newcastle upon Tyne, UK
    Diabet Med 17:807-9. 2000
    ..12 microg/l) then rose significantly before the onset of the respiratory arrest (8.5 h = 0.61 microg/l, 14.5 h = 0.9 microg/l, 18 h = 1.6 microg/l, 25.5 h = 3.1 microg/l, 34 h = 4.6 microg/l and44 h = 19.5 microg/l)...
  22. ncbi request reprint Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment
    A J Dickinson
    Department of Ophthalmology, Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK
    Clin Endocrinol (Oxf) 55:283-303. 2001
    ..Unless a reproducible system of assessment is devised and widely adopted, it will remain difficult to interpret research meaningfully, particularly if results appear to contradict...
  23. pmc A 52-year-old female with a hoarse voice and tingling in the hand
    Salman Razvi
    Endocrine Unit, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
    PLoS Med 4:e29. 2007
  24. ncbi request reprint What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves' disease
    Salman Razvi
    Department of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Eur J Endocrinol 154:783-6. 2006
    ....
  25. doi request reprint Graves orbitopathy: a perspective
    Petros Perros
    Endocrine Unit, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Nat Rev Endocrinol 5:312-8. 2009
    ..The use of immunotherapies for the treatment of GO is currently being explored; of these, rituximab has emerged as a promising new agent...
  26. doi request reprint Thyroid-associated orbitopathy: who and how to treat
    Jane Dickinson
    Department of Ophthalmology, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK
    Endocrinol Metab Clin North Am 38:373-88, ix. 2009
    ..Smoking cessation is recommended at all disease stages. Treatment within a multidisciplinary team consisting of both endocrinologists and ophthalmologists may lead to optimal patient outcomes...
  27. ncbi request reprint Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases
    Latika Sibal
    Department of Endocrinology, Newcastle University Teaching Hospitals, Newcastle upon Tyne, U K
    Pituitary 7:157-63. 2004
    ..To review clinical presentation, management and outcomes following different therapies in patients with pituitary apoplexy...
  28. doi request reprint The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey
    Stephanie Estcourt
    Department of Endocrinology, Royal Devon and Exeter Hospital and Peninsula Medical School, Exeter EX2 5DW, UK
    Eur J Endocrinol 161:483-7. 2009
    ..A recent consensus statement from the European Group on Graves' Orbitopathy recommends referring all patients with thyroid eye disease (TED), except the mildest cases, to a specialist multidisciplinary clinic...
  29. ncbi request reprint Fatal inflammatory hypophysitis
    Elizabeth A McIntyre
    Endocrine Unit, Newcastle Hospitals NHS Trust, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK
    Pituitary 10:107-11. 2007
    ..This is the first description of Wegener's granulomatosis presenting with acute anterior pituitary failure in the absence of other organ involvement and negative serology...
  30. ncbi request reprint Role of the CD40 locus in Graves' disease
    Fiona A Houston
    Institute of Human Genetics, University of Newcastle upon Tyne, United Kingdom
    Thyroid 14:506-9. 2004
    ..We are unable to confirm a role for CD40 in Graves' disease pathogenesis in our U.K. population, however, further studies involving larger patient cohorts and a saturated SNP marker map are required to resolve this issue...
  31. ncbi request reprint Detection of Hurthle cell carcinoma using sestamibi
    Ekaphum Chamnanrabiabkij
    Department of Endocrinology, Freeman Hospital, Newcastle upon Tyne, United Kingdom
    Thyroid 18:575-6. 2008
  32. ncbi request reprint A patient with asymmetric parotid uptake on a diagnostic iodine-131 scan during thyroid cancer follow-up
    John Frew
    Oncology, NCCT, Newcastle upon Tyne, United Kingdom
    Thyroid 17:801-2. 2007
  33. ncbi request reprint The impact of clinical guidelines on surgical management in patients with thyroid cancer
    A W Phillips
    Endocrine Unit, Freeman Hospital, Newcastle upon Tyne, UK
    Clin Oncol (R Coll Radiol) 15:485-9. 2003
    ....
  34. ncbi request reprint Evaluation of serum markers of neuronal damage following severe hypoglycaemia in adults with insulin-treated diabetes mellitus
    M W Strachan
    Department of Diabetes, Royal Infirmary of Edinburgh, UK
    Diabetes Metab Res Rev 15:5-12. 1999
    ..Neurone-specific enolase (NSE) and protein S-100 (S-100) may be used as markers of acute neuronal damage in humans with neurological disorders...
  35. ncbi request reprint Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy
    A Jane Dickinson
    Department of Ophthalmology, Royal Victoria Infirmary, Newcastle on Tyne NE1 4LP, United Kingdom
    J Clin Endocrinol Metab 89:5910-5. 2004
    ..The improvements in both treated and placebo groups emphasize that the results of open studies must be viewed with caution...
  36. ncbi request reprint Apolipoprotein-e influences aspects of intellectual ability in type 1 diabetes
    Stewart C Ferguson
    Department of Diabetes, Royal Infirmary of Edinburgh, Edinburgh, Scotland, U K
    Diabetes 52:145-8. 2003
    ..The APOE epsilon4 genotype is associated with specific cognitive disadvantage in young women with type 1 diabetes. APOE epsilon4 is unlikely to mediate susceptibility to hypoglycemia-induced cognitive disadvantage...
  37. ncbi request reprint Epidemiology of Graves' orbitopathy
    Sudeep Putta-Manohar
    Department of Endocrinology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, UK
    Pediatr Endocrinol Rev 7:182-5. 2010
    ..A small proportion of patients with thyroid orbitopathy have primary hypothyroidism or are euthyroid. Female patients outnumber males by 2-5 to 1. Smoking increases the risk of thyroid orbitopathy up to 8-fold...
  38. ncbi request reprint Management of a pregnant patient with Graves' disease complicated by thionamide-induced neutropenia in the first trimester
    S Davison
    Endocrine Unit, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK
    Clin Endocrinol (Oxf) 54:559-61. 2001
    ..Both mother and fetus may tolerate moderate thyrotoxicosis well in early pregnancy, an alternative that should be considered when thionamide drug therapy is contraindicated...
  39. ncbi request reprint Plasma endothelin response to acute hypoglycaemia in adults with Type 1 diabetes
    R J Wright
    Department of Diabetes, Royal Infirmary of Edinburgh, UK
    Diabet Med 24:1039-42. 2007
    ..To determine whether acute insulin-induced hypoglycaemia provokes a detectable alteration in peripheral plasma endothelin (ET) concentrations in humans with Type 1 diabetes...
  40. ncbi request reprint Glucocorticoids in the medical management of Graves' ophthalmopathy
    R H Hart
    Department of Ophthalmology, Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK
    Minerva Endocrinol 28:223-31. 2003
    ..Recent advances include better definition of factors predictive of response to treatment and the formulation of specific GC regimens that combine high efficacy with a low risk of unwanted side-effects...
  41. pmc Evidence for a new Graves disease susceptibility locus at chromosome 18q21
    B Vaidya
    Department of Endocrinology, School of Clinical Medical Sciences, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH, United Kingdom
    Am J Hum Genet 66:1710-4. 2000
    ..09 (P=.001). Linkage to this region has been demonstrated in type 1 diabetes (IDDM6), rheumatoid arthritis, and systemic lupus erythematosus, which suggests that this locus may have a role in several forms of autoimmunity...
  42. ncbi request reprint The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus
    B Vaidya
    Endocrine Group, Department of Medicine, The Medical School, University of Newcastle upon Tyne, UK
    Hum Mol Genet 8:1195-9. 1999
    ..026), between the markers D6S273 and TNFalpha. We demonstrate that the CTLA-4 locus (lambdas = 2.2) and the MHC locus (lambdas = 1.6) together confer approximately 50% of the inherited susceptibility to GD disease in our population...
  43. ncbi request reprint CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism
    B Vaidya
    Department of Endocrinology, University of Newcastle, Newcastle upon Tyne, UK
    Clin Endocrinol (Oxf) 58:732-5. 2003
    ..Therefore, we have analysed three CTLA4 single nucleotide polymorphisms, including promoter CTLA4(-318)C/T, exon 1 CTLA4(49)A/G and intron 1 CTLA4(1822)C/T in our GD cohort from the UK...
  44. ncbi request reprint 2009 American Thyroid Association guidelines on thyroid nodules
    P Perros
    Department of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Clin Oncol (R Coll Radiol) 22:469-71. 2010
    ....
  45. ncbi request reprint Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population
    H Imrie
    Endocrine Group, Department of Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom NE2 4HH
    J Clin Endocrinol Metab 86:626-30. 2001
    ..4) is likely to exist in the Xp11 region, but we are unable to confirm that the GD1 or the GD3 regions contain major susceptibility loci in our United Kingdom GD population...
  46. ncbi request reprint Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers
    W M Wiersinga
    Department of Endocrinology, Academic Medical Centre, Amsterdam, The Netherlands
    Eur J Endocrinol 155:387-9. 2006
  47. ncbi request reprint Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience
    Mark F Prummel
    Department of Endocrinology and Metabolism, F5 171 Academic Medical Center, University of Amsterdam, Meibergdreef 5, 1105 AZ Amsterdam, The Netherlands
    Eur J Endocrinol 148:491-5. 2003
    ..The European Group on Graves' Orbitopathy aims to overcome this and has designed a preliminary case record form (CRF) to assess Graves' orbitopathy patients. This form was used in this first multi-center study...
  48. doi request reprint Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy
    Luigi Bartalena
    Department of Clinical Medicine, University of Insubria, Varese, Italy
    Thyroid 18:333-46. 2008
  49. pmc Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey
    David McKeag
    Centre for Endocrine and Diabetes Sciences, University Hospital of Wales, Cardiff CF 4 4XN, UK
    Br J Ophthalmol 91:455-8. 2007
    ..This study was performed to determine clinical features of dysthyroid optic neuropathy (DON) across Europe...
  50. ncbi request reprint Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility
    Alison Sutherland
    Institute of Human Genetics, Newcastle University, Newcastle upon Tyne NE1 3BZ, United Kingdom
    J Clin Endocrinol Metab 92:3338-41. 2007
    ..Previous investigations have also demonstrated that an intronic polymorphism (termed PD1.3; SNP ID rs11568821) in the programmed cell death (PDCD1) gene was associated with systemic lupus erythematosus and rheumatoid arthritis...
  51. ncbi request reprint Prevention of thyroid associated-ophthalmopathy in children and adults: current views and management of preventable risk factors
    Gerasimos E Krassas
    Department of Endocrinology, Diabetes and Metabolism, Panagia General Hospital, Thessaloniki, Greece
    Pediatr Endocrinol Rev 4:218-24. 2007
    ..Passive smoking seems to exacerbate autoimmune thyroid disease (AITD) in general, and may have a deleterious effect on childhood GO in particular, therefore avoidance of passive smoking is likely to be beneficial...
  52. ncbi request reprint Introduction to the updated guidelines on the management of thyroid cancer
    Petros Perros
    Clin Med 7:321-2. 2007
  53. doi request reprint Erectile dysfunction in patients with hyper- and hypothyroidism: how common and should we treat?
    Gerasimos E Krassas
    Department of Endocrinology, Diabetes, and Metabolism, Panagia General Hospital, North Plastira 22, North Krini, 55132 Thessaloniki, Greece
    J Clin Endocrinol Metab 93:1815-9. 2008
    ..Erectile dysfunction (ED) is associated with numerous diseases and aging...
  54. ncbi request reprint Medical image. Acute pretibial myxoedema following thyroidectomy for Graves' disease
    Akheel A Syed
    Salford Royal NHS Foundation Trust, Salford M6 8HD, United Kingdom
    N Z Med J 121:108-9. 2008
  55. doi request reprint Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
    Luigi Bartalena
    Department of Clinical Medicine, University of Insubria, 21100 Varese, Italy
    Eur J Endocrinol 158:273-85. 2008